Prosecution Insights
Last updated: November 15, 2026

Bionano Genomics Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Analysis

Bionano Genomics Inc. is currently managing 3 pending office actions within the Semiconductors, Circuits & Optics technology area. These 3 actions are spread across 3 distinct examiners and 3 distinct art units. This one-to-one ratio between actions, examiners, and art units indicates a diverse set of technologies or a broad application of its core intellectual property across the Semiconductors, Circuits & Optics field.

DEVITO, ALEX T is the busiest examiner for the portfolio, though they only handle 1 pending office action. Because each of the 3 distinct examiners is responsible for exactly one of the 3 pending office actions, no single examiner dominates the company's current prosecution landscape. The involvement of 3 distinct art units suggests that the filings are being reviewed by multiple specialized groups. This distribution means that the outcome of 1 pending office action will not necessarily influence the others, as they are being reviewed by 3 distinct examiners.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (67%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (67%)
Double-patenting only1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
33% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DEVITO, ALEX T 1 72.1% +12.3%
GERIDO, DWAN A 1 58.1% +30.3%
YU, DELPHINUS DOU YI 1 37.5% +71.4%

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
15734918 LABELING OF DNA YU, DELPHINUS DOU YI 12d
18810371 INTEGRATED ANALYSIS DEVICES AND RELATED FABRICATION METHODS AND ANALYSIS TECHNIQUES DEVITO, ALEX T —
17690961 PHOTOCLEAVAGE METHOD AND APPARATUS TO CLEAN FLUIDIC DEVICES GERIDO, DWAN A —

Top Art Units

Art UnitApps
2855 1
1797 1
1636 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18810371 INTEGRATED ANALYSIS DEVICES AND RELATED FABRICATION METHODS AND ANALYSIS TECHNIQUES DEVITO, ALEX T 2855 DP Non-Final OA — Pending Aug 20, 2024
17690961 PHOTOCLEAVAGE METHOD AND APPARATUS TO CLEAN FLUIDIC DEVICES GERIDO, DWAN A 1797 §103 Final Rejection — Pending Mar 09, 2022
15734918 LABELING OF DNA YU, DELPHINUS DOU YI 1636 §103 Final Rejection 12d Pending Dec 03, 2020

Managing Bionano Genomics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Bionano Genomics Inc. have?

Bionano Genomics Inc. has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Bionano Genomics Inc. applications?

Alex T Devito has the most, with 1 of Bionano Genomics Inc.'s pending office actions.

What technology area are Bionano Genomics Inc.'s patent applications in?

Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month